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        Introduction 
  Excitotoxicity is the main mechanism underlying neuronal 
death in stroke, anoxia, and seizure. The extracellular serine 
protease tissue plasminogen activator (tPA) and its zymogen 
substrate plasminogen are critical to excitotoxic neuronal death 
because mice defi  cient in either of these genes are resistant to 
excitotoxic neurodegeneration (  Tsirka et al., 1995  ,   1997  ). Fur-
ther study showed that the tPA/plasmin proteolytic cascade 
participates in excitotoxic neuronal death by degrading the ECM 
protein laminin (  Chen and Strickland, 1997  ;  Nagai  et  al., 1999 ). 
  Laminins are heterotrimeric ECM glycoproteins that play 
important roles in the nervous system. Laminins are expressed 
in the mouse hippocampus and disappear after excitotoxin in-
jection (  Hagg et al., 1989  ,   1997  ;   Jucker et al., 1996  ;   Chen and 
Strickland, 1997  ;   Tian et al., 1997  ;   Nagai et al., 1999  ;   Indyk 
et al., 2003  ). Laminin disappearance precedes neuronal death, is 
spatially coincident with regions that exhibit neuronal loss, and 
is blocked by either tPA defi  ciency or infusion of a plasmin in-
hibitor, both of which also prevent neuronal degeneration. These 
studies indicate that laminin is a key player in excitotoxic neu-
ronal degeneration. However, the mechanism of how laminin 
degradation participates in neuronal death is not clear. 
  To study the mechanistic role of laminin in excitotoxic 
neuronal death, we generated a laminin    1  (lam  1)  conditional 
knockout (KO) mouse line using the Cre/loxP system (  Chen 
and Strickland, 2003  ) and disrupted laminin expression in the 
hippocampus (hereafter referred to as lam    1 KO mice). Analy-
sis of these mice revealed that they were resistant to excitotoxic 
neuronal death. We established that laminin degradation prod-
ucts, which are produced via the tPA/plasmin system, lead to 
up-regulation of the KA1 subunit of the kainate (KA) receptor 
and subsequent neuronal death. Consistent with this conclusion, 
specifi  c interference of KA1 subunit function rendered wild-
type mice resistant to excitotoxic degeneration. 
  Our results illuminate a novel excitotoxic pathway in 
which KA up-regulates tPA, leading to laminin degradation by 
plasmin. The products of laminin proteolysis up-regulate a key 
D
egradation of the extracellular matrix (ECM) pro-
tein laminin contributes to excitotoxic cell death in 
the hippocampus, but the mechanism of this effect 
is unknown. To study this process, we disrupted laminin     1 
(lam    1) expression in the hippocampus. Lam    1 knock-
out (KO) and control mice had similar basal expression of 
kainate (KA) receptors, but the lam    1 KO mice were re-
sistant to KA-induced neuronal death. After KA injection, 
KA1 subunit levels increased in control mice but were un-
changed in lam    1 KO mice. KA1 levels in tissue plasmin-
ogen activator (tPA)  –  KO mice were also unchanged after 
KA, indicating that both tPA and laminin were necessary 
for KA1 up-regulation after KA injection. Infusion of plasmin-
digested laminin-1 into the hippocampus of lam    1 or tPA 
KO mice restored KA1 up-regulation and KA-induced 
neuronal degeneration. Interfering with KA1 function with 
a speciﬁ   c anti-KA1 antibody protected against KA-
induced neuronal death both in vitro and in vivo. These 
results demonstrate a novel pathway for neurodegenera-
tion involving proteolysis of the ECM and KA1 KA recep-
tor subunit up-regulation.
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jcb.200803107/DC1). Consistent with a previous study (  Salles 
and Strickland, 2002  ), KA-induced neuronal death was great-
est in the CA1 region, although there was substantial neuronal 
death in the CA3 region. 
  To investigate the time course of neuroprotection after 
lam    1 depletion, we compared neuronal death between control 
and lam    1 KO mice 6 d after KA injection. Lam   1  KO  mice 
still exhibited resistance to neuronal death (Fig. S1 B). This re-
sult demonstrates that the neuroprotective effect in lam   1  KO 
mice is a long-term effect. 
  KA-induced c-fos protein expression in the 
hippocampus of lam    1 KO mice is impaired 
  Because there was little neuronal cell death after KA injection 
in the hippocampus of the lam    1 KO mice, it was possible that 
the neurons were not stimulated by KA. c-fos is an immediate 
early gene that is induced after KA injection into the hippo-
campus (  Le Gal La Salle, 1988  ;   Lerea and McNamara, 1993  ; 
  Kasof et al., 1995  ) and can be used to monitor neuronal re-
sponse. To investigate whether neurons were stimulated by 
KA, we compared c-fos expression at 0, 2, 4, and 6 h after KA 
injection in the hippocampus of control and lam    1 KO mice 
by immunohistochemistry. Without KA injection, there was 
no c-fos expression in the hippocampus of either control 
(fl  oxed lam    1 mice) or lam    1 KO mice (  Fig. 2 A  , a and c). 
[ID]FIG2 [/ID]  
c-fos was induced similarly in the DG of both control and lam   1 
KO mice 1 (not depicted) and 2 h after KA injection (  Fig. 2 A  , 
e and g). 4 h after KA injection, c-fos expression spread to 
CA1  –  3 regions in control mice but did not spread to CA1 and 
only minimally to CA3 in lam    1 KO mice (  Fig. 2 A  , i and k). 
6 h after KA injection, c-fos expression was decreased in the 
control mice compared with 4 h (  Fig. 2 A  , i and m). However, 
in lam    1 KO mice, c-fos expression disappeared 6 h after KA 
injection (  Fig. 2 A  , o). DAPI staining showed similar patterns 
of hippocampal neuronal layers between control and lam   1 
KO mice at early time points after KA injections (  Fig. 2 A  , 
b, d, f, h, j, l, n, and p). Quantitative analyses by Western blotting 
showed signifi  cantly less c-fos induction in the whole hippo-
campus of lam    1 KO mice compared with control mice 6 h 
after KA injection (  n   = 7 per group;   Fig. 2 B  ). These results 
demonstrate that KA-induced c-fos expression in the DG re-
gion of lam    1 KO mice is initially identical to wild-type mice, 
but the induction fails to propagate to other regions, notably 
CA1. The failure of c-fos expression to spread in the lam   1 
KO mice could be related to the neuroprotection observed in 
the absence of laminin. 
  Because c-fos induction in the hippocampus of lam   1  KO 
mice after KA injection was impaired, it was possible that the 
expression of KA receptors was affected. To investigate this 
possibility, we compared the expression of KA receptor sub-
units in the hippocampus of control and lam    1 KO mice. There 
are fi  ve KA receptor subunits: KA1, KA2, GluR5, GluR6, and 
GluR7 (  Lerma et al., 2001  ;   Lerma, 2006  ). KA1 and KA2 sub-
units are high affi  nity receptors, whereas GluR5, GluR6, and 
GluR7 are low affi  nity receptors (  London and Coyle, 1979  ; 
  Unnerstall and Wamsley, 1983  ;   Hampson et al., 1987  ). Western 
blot analysis revealed that all fi  ve subunits were expressed in the 
KA receptor, which increases the sensitivity to excitotoxins and 
eventually causes neuronal death. This pathway suggests new 
approaches to countering the neuronal loss associated with 
excitotoxic injury in disorders like stroke. 
  Results 
  Lam    1 depletion in the hippocampus 
renders neurons resistant to KA-induced 
neuronal cell death 
  Injection of excitotoxins into the hippocampus causes massive 
cell death in the cornu ammonis regions of the hippocampus 
(  Coyle et al., 1978  ). Previous studies have implicated laminin in 
this process (  Chen and Strickland, 1997  ;   Chen et al., 2003  ). To 
further study the role of laminin in excitotoxic neuronal degen-
eration, we created a mouse line in which the lam   1  gene  is 
fl  oxed (  Chen and Strickland, 2003  ) and disrupted lam   1  ex-
pression in the hippocampus using Cre recombinase controlled 
by calcium/calmodulin-dependent protein kinase II      (CaMKII) 
promoter (  Dragatsis and Zeitlin, 2000  ). To analyze where 
Cre was expressed in the adult hippocampus, we created mice 
containing the CaMKII-Cre transgene and a double reporter 
gene in which GFP expression is activated by Cre-dependent 
excision of the lacZ gene together with a stop codon (lacZ/
EGFP reporter mice;   Novak et al., 2000  ). In these mice, GFP 
was expressed in the CA1 neuronal layers and dentate gyrus 
(DG) in the hippocampus (  Fig. 1 C  ), indicating Cre expression 
in these regions. 
[ID]FIG1[/ID]  
  In mice homozygous for the fl  oxed lam    1 gene but not 
containing CaMKII-Cre (control mice), lam    1 was expressed 
in the hippocampus as shown previously (  Fig. 1, A and D  ;   Indyk 
et al., 2003  ;   Yin et al., 2003  ). However, in mice homozygous for 
the fl  oxed lam    1 gene and containing the CaMKII-Cre trans-
gene (lam    1 KO mice), lam    1 expression was disrupted in the 
CA1 (  Fig. 1 B  , arrows; magnifi  ed in E) and DG regions (  Fig. 1 B  , 
asterisk) where Cre was expressed. In the CA2 region, where 
GFP is not expressed (  Fig. 1 C  , arrowheads), lam   1  was  still 
expressed in the KO mice (  Fig. 1 B  , arrowheads). DAPI staining 
showed that the neuronal cell layers were similar between con-
trol and lam    1 KO hippocampi (  Fig. 1, F and G  ). Thus, this 
method depletes lam    1 in the CA1 and DG regions. 
 Although  lam   1 expression was disrupted both in the 
CA1 and DG regions, intrahippocampal KA injection only in-
duces neuronal cell death in the cornu ammonis region (  Coyle 
et al., 1978  ). Therefore, we focused on how the lack of laminin 
expression in CA1 affects excitotoxic neuronal cell death. 2 d 
after intrahippocampal KA injection, there was substantial 
neuronal cell death in the CA1 of control mice (fl  oxed lam   1 
mice) as revealed by silver staining (  Fig. 1, H and J  ). In con-
trast, there was little neuronal death in the CA1 region of the 
lam    1 KO mice (  Fig. 1, I and K  ). Quantitative analysis from 
control and lam    1 KO mice (  n   = 7 per group) showed a signifi  -
cant difference in KA-induced neuronal death in the CA1 re-
gion (  Fig. 1 L  ). 
  In the CA2 and CA3 regions, the numbers of dead 
neurons between control and lam    1 KO mice were similar 
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/1301 LAMININ AND KA1 IN EXCITOTOXIC NEURONAL DEATH   • Chen et al. 
pathway plays an important role in mediating excitotoxic neu-
ronal cell death (  Yang et al., 1997  ;   Saporito et al., 1998  ; 
 Behrens  et  al., 1999  ;   Wu et al., 2000  ;   Savinainen et al., 2001  ; 
  Borsello et al., 2003  ;   Kuan et al., 2003  ;   Zhang et al., 2006  ). 
Therefore, we tested whether activation of the JNK signaling 
pathway was affected in lam    1 KO mice. Because JNK can be 
activated by MAPK kinase 4 (MKK4;   Cuenda, 2000  ), we ana-
lyzed MKK4 phosphorylation levels in control and lam   1  KO 
mice after KA injection. Phosphorylation of MKK4 was dra-
matically reduced in lam    1 KO mice compared with control 
hippocampus of control and lam    1 KO mice, and the expres-
sion levels of all fi  ve subunits were similar between these mice 
( Fig.  2  C ). 
  Activation of intracellular death signaling 
pathways is impaired in lam    1 KO mice 
  c-fos was not induced in the CA1 region of lam    1 KO mice 
after KA injection, indicating that the excitotoxic resistance 
phenotype could be caused by a failure of intracellular death 
signaling pathway activation. The JNK intracellular signaling 
  Figure 1.       Lam    1 KO mice were resistant to KA-induced neuronal death in the hippocampus.   (A and B) Lam    1 was expressed in the hippocampal neuronal 
layers CA1 (A, arrows), CA2/3 (A, arrowhead), and DG (A, asterisk) of control (Con) mice (ﬂ  oxed lam    1 mice) but was dramatically decreased in the 
CA1 and DG regions of the lam    1 KO mice (B, arrows and asterisk). In the CA2 region, lam    1 was still expressed (A and B, arrowheads). Higher magni-
ﬁ  cation of boxed areas in A and B are shown in D and E, respectively. (C) In the lacZ/EGFP reporter mice that also carry the CaMKII-Cre transgene, GFP 
(indication of Cre activity) was expressed in the hippocampal neuronal layers CA1 (arrows) and DG (asterisk), whereas GFP was not expressed in the CA2 
region (arrowhead indicates background GFP activity). The GFP expression regions correlated well with the regions of lam    1 disruption in the KO mice. 
(F and G) DAPI staining revealed a similar pattern of hippocampal neuronal layers between control and lam    1 KO mice. (H and I) Silver staining shows 
that intrahippocampal KA injection  –  induced neuronal death in the CA1 region of lam    1 KO mice (I) was much less than that of controls (H; H  –  K, arrows). 
Higher magniﬁ  cation of boxed areas in H and I are shown in J and K, respectively. (L) Quantitative analysis of KA-induced neuronal death in control and 
KO mice (seven mice in each genotype). Error bars indicate SEM. Bars: (A  –  C and F  –  I) 0.5 mm; (D, E, J, and K) 50   μ  m.     JCB • VOLUME 183 • NUMBER 7 • 2008  1302
between PBS- and KA-injected hippocampi. The KA1 subunit 
was dramatically increased after KA injection; however, all 
other subunits were unchanged (  Fig. 4 A  ). 
[ID]FIG4[/ID]  These results demon-
strate that all fi  ve subunits of the KA receptors were expressed 
in the mouse hippocampus, but after KA injection, only the 
KA1 subunit was signifi  cantly increased. 
  To investigate how KA injection affects KA receptor 
expression in lam    1 KO mice, we compared the expression 
levels of KA receptor subunits in lam    1 KO mice after PBS 
or KA injection. KA1 subunit expression in the hippocampus 
of PBS- and KA-injected lam    1 KO mice was similar and 
also similar to PBS-injected control mice, demonstrating a 
lack of KA1 subunit up-regulation by KA (  Fig. 4 A  ). Analy-
ses of other KA receptor subunit expression levels revealed 
that none are signifi  cantly changed in lam    1 KO mice after 
KA injection (  Fig. 4 A  ). 
mice after KA injection (  Fig. 3 A  ). 
[ID]FIG3[/ID]  Phosphorylated JNK was 
detected in control but not in lam    1 KO mice (  Fig. 3 B  ). 
  Another component of this pathway is c-Jun, which can 
be phosphorylated by activated JNK (  Manning and Davis, 
2003  ). After KA injection, phosphorylated c-Jun was reduced in 
lam    1 KO mice compared with control mice (  Fig. 3 C  ). These 
results demonstrate that activation of multiple components of 
the intracellular death signaling pathway was impaired in lam  1 
KO mice after KA injection. 
  KA speciﬁ  cally induces up-regulation of 
the KA1 subunit of the KA receptor in the 
hippocampus in control but not in lam    1 
KO mice 
  To analyze how KA injection affects the expression of KA re-
ceptors, we compared the expression levels of the fi  ve subunits 
  Figure 2.       KA-induced c-fos protein expression in the hippocampus of lam    1 KO mice was impaired.   (A) Time course of c-fos expression in the hippo-
campus of control (Con) and lam    1 KO mice after KA injection. Under basal conditions, c-fos was not expressed in the hippocampus of either control 
(ﬂ  oxed lam    1 mice) or lam    1 KO mice (a and c). 2 h after KA injection, c-fos was similarly induced in the DG of either control or lam    1 KO mice (e and g, 
arrows). 4 h after KA injection, c-fos was expressed in the CA1, CA3, and DG regions of control mice (i, arrow indicates c-fos expression in the CA1 
region) but was absent in the CA1 region of lam    1 KO mice (k, arrow). 6 h after KA injection, c-fos expression in the whole hippocampus of control mice 
was decreased compared with 4 h and had almost completely disappeared in lam    1 KO (m and o, arrows). DAPI staining showed that the hippocampal 
neuronal layers at early time points after KA injection were similar between control and lam    1 KO mice (b, d, f, h, j, l, n, and p). (B) Western blot analysis 
also showed that c-fos expression in the whole hippocampus of lam    1 KO mice was much less than that of controls 6 h after KA injection. Quantitative 
analysis of Western blots of c-fos expression in control and lam    1 KO mice after KA injection are shown on the right of the Western blot (  n   = 7 per geno-
type; Western blot signal intensities were normalized to actin). (C) Western blot analysis showed that under basal conditions, all ﬁ  ve subunits of the KA 
receptor were expressed in the hippocampus of control and lam    1 KO mice and that the expression levels were similar (signal intensities were normalized 
to actin). Error bars indicate SEM.     1303 LAMININ AND KA1 IN EXCITOTOXIC NEURONAL DEATH   • Chen et al. 
(  Fig. 4 B  , c and d). The cell types that exhibited increased KA1 
expression in the CA1 region were pyramidal neurons (unpub-
lished data). To confi  rm the specifi  city of the KA1 antibodies 
used for immunohistochemistry, we used a KA1 antibody  –
  blocking peptide. Our results showed that the blocking peptide 
completely eliminated the KA1 immunoreactivity in the hippo-
campus (Fig. S3 A, available at http://www.jcb.org/cgi/content/
full/jcb.200803107/DC1). These results demonstrate that after 
KA injection, the KA1 subunit is up-regulated mainly in the 
pyramidal neurons of the CA1 region. 
  We compared KA1 expression patterns between control 
and lam    1 KO mice after KA injection by immunohistochemis-
try. The KA1 expression pattern between PBS-injected control 
and lam    1 KO mice was similar (  Fig. 4 B  , a, b, e, and f). How-
ever, 2 h after KA injection, the pattern between these mice was 
different; in KA-injected mice, KA1 was increased in the CA1 
region of controls but not in lam    1 KO mice (  Fig. 4 B  , g and h). 
In the CA3 region of both control and lam    1 KO mice, KA1 
expression was slightly decreased (  Fig. 4 B  , c and g [arrows] 
  Because KA could also activate AMPA (   -amino-3-
hydroxy-5-methyl-isoxazolepropionic acid) receptors (  Arundine 
and Tymianski, 2003  ) and affect their expression, we com-
pared AMPA receptor subunit expression between control and 
lam    1 KO mice after KA injection. Our results show there 
were no signifi  cant differences in the expression levels of any 
AMPA receptor subunits (Fig. S2, available at http://www.jcb
.org/cgi/content/full/jcb.200803107/DC1). 
  To determine which regions of the hippocampus and what 
cell types exhibit increased KA1 expression, we performed 
KA1 immunohistochemistry (  Fig. 4 B  ). In PBS-injected con-
trol mice, KA1 immunoreactivity was detected in the CA1 and 
CA3 regions but not the DG, which agrees with a previous 
study (  Darstein et al., 2003  ). KA1 immunoreactivity in CA3 
was stronger than in the CA1 region (  Fig. 4 B  , a and b). How-
ever, after KA injection, KA1 immunoreactivity in the CA1 re-
gion was stronger than that of PBS-injected mice. In contrast 
to PBS-injected mice, the KA1 immunoreactivity in the CA1 
region of KA-injected mice was stronger than in the CA3 region 
  Figure 3.       Activation of intracellular death signaling pathways was impaired in lam    1 KO mice.   (A  –  C) The phosphorylation levels of MKK4 (A), JNK (B), 
and c-Jun (C) were signiﬁ  cantly less in the hippocampus of lam    1 KO mice compared with those of control (Con) mice 2 h after KA injection. Quantitative 
analyses are shown as bar graphs directly below the respective Western blots (  n   = 7 per genotype; signal intensities were normalized to actin). Error bars 
indicate SEM.     JCB • VOLUME 183 • NUMBER 7 • 2008  1304
paired in both lam    1 KO and tPA KO mice, suggesting that 
tPA/plasmin/laminin molecules form a network that participates 
in excitotoxicity by regulating KA1 subunit expression. 
  Plasmin-digested laminin restores KA1 
subunit expression after KA injection in 
both tPA and lam    1 KO mice, whereas 
intact laminin only restores KA1 subunit 
expression in lam    1 KO mice but not tPA 
KO mice 
  tPA, plasminogen, and lam    1 KO mice are all resistant to excito-
toxic neuronal degeneration (  Tsirka et al., 1995  ,   1997  ), and 
the KA1 subunit is not up-regulated after KA injection in either 
tPA KO or lam    1 KO mice. An explanation for this observation 
could be that plasmin-catalyzed degradation of laminin gener-
ates fragments that cooperate with KA to stimulate KA1 ex-
pression. To test this hypothesis, we infused plasmin-digested 
laminin-1 into lam    1 KO mice (plasmin was heat inactivated 
before infusion). 6 d later, either KA or PBS (for control) was 
injected. Infusion of plasmin-digested laminin followed by the 
injection of PBS had no effect on KA1 levels (  Fig. 6  ), indicating 
compared with a and e). All of these experiments indicate that 
KA-induced KA1 subunit up-regulation was impaired in lam   1 
KO mice. 
  KA-induced up-regulation of KA1 receptor 
expression in the hippocampus of tPA KO 
mice is also impaired 
  Previous studies showed that the tPA/plasmin proteolytic cas-
cade is involved in laminin degradation and neuronal death 
(  Tsirka et al., 1995  ,   1997  ;   Chen and Strickland, 1997  ). To deter-
mine whether KA1 is up-regulated in tPA KO mice after KA in-
jection, we analyzed KA1 expression in these mice under basal 
conditions and after KA injection. Under basal conditions, the 
expression of KA1 was similar in the hippocampus of control 
and tPA KO mice (  Fig. 5  ). 
[ID]FIG5[/ID]  However, after KA injection, KA1 
levels were up-regulated in the hippocampus of control mice 
but not in that of tPA KO mice. The KA1 expression levels in 
tPA KO mice after KA injection were similar to PBS-injected 
tPA KO mice or PBS-injected control animals and were also 
similar to the basal expression levels (  Fig. 5  ). These results in-
dicate that KA-induced up-regulation of the KA1 subunit is im-
  Figure 4.       KA speciﬁ  cally up-regulates the KA1 subunit of the KA receptor in the hippocampus in control but not in lam    1 KO mice.   (A) After KA injection, 
only the KA1 subunit was signiﬁ  cantly higher in the hippocampus of control (Con) mice compared with PBS-injected control mice and lam    1 KO mice 
injected with PBS or KA. All other subunits  ’   expression levels remained similar between PBS- or KA-injected control and KO mice. Quantitative analyses 
were performed by one-way ANOVA and are shown as bar graphs (  n   = 7 per group for each experiment; Western blot signal intensities were normal-
ized to actin). (B) Immunohistochemistry of KA1 subunit in PBS- or KA-injected control and lam    1 KO mice. (a and b) In PBS-injected control mice, KA1 
was expressed in the CA1 and CA3 regions but was not detected in the DG. (c and d) However, 2 h after KA injection, KA1 expression was dramatically 
increased in the CA1 region. KA1 expression in CA3 and mossy ﬁ  ber pathway was slightly decreased (arrows), which may suggest early neuronal dam-
age. (e  –  h) In lam    1 KO mice, the expression levels of KA1 between PBS- and KA-injected mice were similar. Higher magniﬁ  cation of boxed areas in a, c, 
e, and g are shown in b, d, f, and h, respectively. Error bars indicate SEM. Bars: (a, c, e, and g) 0.5 mm; (b, d, f, and h) 20   μ  m.     1305 LAMININ AND KA1 IN EXCITOTOXIC NEURONAL DEATH   • Chen et al. 
pression level (Fig. S3 C). These results indicate that digestion 
of laminin by plasmin generated fragments that can preferen-
tially up-regulate KA1 subunit expression after KA exposure. 
  Plasmin-digested laminin restores neuronal 
sensitivity to excitotoxicity in both lam    1 
and tPA KO mice 
  Because infusion of plasmin-digested laminin restored KA1 
up-regulation in both lam    1 and tPA KO mice after KA injec-
tion, we further investigated whether restoration of KA1 sub-
unit up-regulation in these KO mice is suffi  cient to rescue 
neuronal sensitivity to KA-induced neuronal death. After infu-
sion, the lam    1 KO mice were injected with KA. Mice infused 
with control buffer showed very little neuronal death 2 d after 
KA injection (  Fig. 7, A and B  ). 
[ID]FIG7[/ID]  However, plasmin-digested 
laminin-infused mice exhibited much more neuronal loss than 
control buffer  –  infused mice (  Fig. 7, C and D  ). The difference 
in the number of dead neurons between buffer-infused and 
plasmin-digested laminin-infused lam    1 KO mice was signifi  -
cant (  Fig. 7 G  ). The numbers of dead neurons in plasmin-
digested laminin-infused lam    1 KO were similar to control 
mice (  Fig. 7, C  –  G  ). Furthermore, infusion of intact laminin in 
that this material alone does not stimulate KA1 subunit ex  p ression. 
[ID]FIG6[/ID]  
However, 2 h after KA injection, the KA1 levels in plasmin-
digested laminin-infused mice were signifi  cantly higher than 
control buffer  –  infused mice (  Fig. 6  ). Similar results were ob-
tained when the same experiment was performed in tPA KO 
mice; after KA injection, the KA1 levels in the plasmin-digested 
laminin-infused mice were signifi   cantly higher than control 
buffer – infused  mice  ( Fig.  6 ). 
  We further investigated whether this effect is dependent 
on degradation of laminin by comparing intact laminin and 
plasmin-digested laminin intrahippocampally infused into 
lam    1 KO or tPA KO mice. Infusion of intact laminin into 
lam    1 KO mice also up-regulated KA1 expression after KA in-
jection (  Fig. 6  ) because these mice have an intact tPA/plasmin 
system and can degrade the intact laminin. In contrast, intact 
laminin had no signifi  cant effect on KA1 expression in tPA KO 
mice because in the absence of tPA, this infused material cannot 
be degraded into the active degradation products (  Fig. 6  ). We 
also compared KA1 expression levels between plasmin-
digested fi  bronectin-infused mice and plasmin-digested laminin- 
or control buffer  –  infused mice. Our results showed that 
plasmin-digested fi  bronectin did not up-regulate the KA1 ex-
  Figure 5.       KA-induced up-regulation of KA1 
subunit expression in the hippocampus of tPA 
KO mice was also impaired.   Western blot 
analy  ses showed that KA1 subunit expression 
in the hippocampi of control and tPA KO mice 
was similar under basal conditions. However, 
2 h after KA injection, the expression levels 
of KA1 were signiﬁ  cantly higher in the hippo-
campi of control mice compared with tPA 
KO mice injected with KA or PBS or control 
mice injected with PBS. Quantitative analysis 
from Western blots was performed by one-way 
ANOVA and is shown below the panel (  n   = 7 
per group; Western blot signal intensities were 
normalized to actin). Con and CO, control. Error 
bars indicate SEM.     JCB • VOLUME 183 • NUMBER 7 • 2008  1306
could restore neuronal sensitivity to excitotoxins in tPA KO 
mice. In contrast to our previous fi  ndings (  Chen et al., 2003  ), 
this intact laminin did not rescue KA-induced neurodegenera-
tion in tPA KO mice (unpublished data). One possible expla-
nation for the difference between our previous and present 
results is in the batch of laminin used. If our previous batch of 
intact laminin (no longer available) had some degradation, it 
could have facilitated KA-induced neuronal death in tPA KO 
mice. These results demonstrate that only infusion of plasmin-
digested laminin into the hippocampus of tPA KO mice re-
stores neuronal sensitivity to excitotoxins. 
  Interfering with KA1 function in control 
mice desensitizes neurons to KA-induced 
neuronal cell death in vitro and in vivo 
  To investigate the relationship between KA1 subunit up-regula-
tion and excitotoxic neuronal death, we compared the time 
course of KA-induced KA1 up-regulation and KA-induced 
neuronal death (  Andersson et al., 1991  ) using Fluoro Jade B 
(FJB) staining to label degenerating cells (  Schmued and Hopkins, 
2000  ). A time course of KA1 expression after KA injection 
lam    1 KO mice also restored neuronal sensitivity to excito-
toxins (unpublished data). These results demonstrate that infu-
sion of either intact or plasmin-digested laminin into the 
hippocampus of lam    1 KO mice restores KA1 subunit up-
regulation and neuronal sensitivity to excitotoxins. 
  We have previously reported that infusion of plasmin-
digested laminin into the hippocampus of tPA KO mice can 
infl  uence KA-induced neuronal death (  Chen et al., 2003  ). We 
have reinvestigated this result in light of the aforementioned 
experiments. In tPA KO mice infused with control buffer, 
there was very little neuronal death 2 d after KA injection 
(Fig. S4, A and B, available at http://www.jcb.org/cgi/content/
full/jcb.200803107/DC1). However, tPA KO mice infused 
with plasmin-digested laminin exhibited much more neuronal 
loss than animals infused with control buffer (Fig. S4, C and D) 
and were comparable with control mice (Fig. S4, C  –  G). 
The difference in the number of dead neurons between plas-
min-digested laminin-infused and buffer-infused tPA KO mice 
was signifi  cant (Fig. S4 G). Because infusion of intact laminin 
into the hippocampus of tPA KO mice did not up-regulate 
KA1 expression (  Fig. 6  ), we analyzed whether intact laminin 
  Figure 6.       Infusion of plasmin-digested laminin restores KA1 subunit up-regulation in both tPA and lam    1 KO mice after KA injection, whereas infusion of 
intact laminin only restores KA1 levels in lam    1 but not tPA KO mice.   Lam    1 or tPA KO mice were infused with plasmin-digested laminin, control buffer, 
intact laminin, or PBS for 6 d. Mice were intrahippocampally injected with PBS or KA. Infusion of plasmin-digested laminin up-regulated KA1 in both tPA 
and lam    1 KO mice after KA injection, but infusion of intact laminin only up-regulated KA1 expression in lam    1 KO mice, not tPA KO mice, after KA injec-
tion. In all other treatments, KA1 expression levels are similar. Quantitative analysis of Western blots was performed by one-way ANOVA and is shown 
as a bar graph (  n   = 7 per genotype; Western blot signal intensities were normalized to actin). Buf, buffer; Ln-P, plasmin-digested laminin-1; Ln, laminin-1. 
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bodies, which was raised against a domain of the extracellular 
region of KA1 subunit, exhibited a signifi  cant neuronal protec-
tive effect (see following paragraph;   Fig. 8  ). 
[ID]FIG8[/ID]  The other two 
showed no signifi  cant effect (unpublished data). 
  Western blot analysis using this antibody revealed that it 
is specifi  c and stained a single band corresponding to the size of 
the KA1 subunit (Fig. S3 B). Immunocytochemistry analysis 
revealed that the KA1 subunit is expressed in neurons in vitro 
(  Fig. 8  , a and b). Therefore, neuronal cultures were treated with 
control IgG or anti-KA1 antibody 3 h before KA treatment, and 
24 h later, fresh IgG or anti-KA1 antibody was readded. 2 d after 
KA treatment, neuronal morphological changes were analyzed 
by neuronal class III    -tubulin  (TuJ1)  immunocytochemistry, 
and cell death was analyzed by TUNEL assay. In IgG-treated 
cultures, KA induced the degradation of TuJ1-positive cells as 
revealed by immunocytochemistry (  Fig. 8  , compare d with e). 
However, in anti-KA1 antibody  –  treated neuronal cultures, KA 
caused only slight neuronal morphological changes, and most 
neurites maintained their integrity (  Fig. 8  , compare d  –  f). To 
quantify the neuronal protective effect of the anti-KA1 anti-
body, we compared the percentage of TUNEL-positive nuclei 
with control IgG and anti-KA1 antibody  –  treated cultures after 
KA. In anti-KA1 antibody  –  treated cultures, KA induced 
showed that KA1 increased at 1 h, peaked at 2 h, returned to 
normal levels at 6 h, and then decreased (Fig. S5 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200803107/DC1), pre-
sumably as a result of neuronal loss. A time-course analysis of 
KA-induced neuronal cell death showed that neuronal loss was 
fi  rst detected 6 h after KA injection and gradually increased 
over the next 2 d (Fig. S5 B). The CA1 region showed the great-
est neuronal death. Because KA1 expression is up-regulated in 
a 1  –  4-h time frame and is mostly increased in CA1 after KA 
injection, whereas neuronal death begins at 6 h and is most ob-
vious in the CA1 region, these results demonstrate that KA1 
up-regulation precedes neuronal death and is spatially correlated 
to the regions that show the most profound degeneration. 
  The aforementioned experiments established a correlation 
between KA1 up-regulation and excitotoxic neuronal death. To 
further investigate this correlation, we investigated the effect of 
interfering with KA1 function on KA-induced neuronal cell 
death. We screened fi  ve different anti-KA1 antibodies for their 
potential binding capacity to KA1 subunit by immunohisto-
chemistry using fresh frozen brain sections. Among the fi  ve anti-
bodies, three showed staining in the hippocampal CA1 and CA3 
regions. We analyzed the effect of these three anti-KA1 anti-
bodies on KA-induced neuronal death in vitro. One of the anti-
  Figure 7.       Infusion of plasmin-digested laminin into lam    1 KO mice restores neuronal sensitivity to excitotoxins.   (A  –  D) Lam    1 KO mice were infused with 
control buffer (A and B) or plasmin-digested laminin (C and D) for 5 d. Control mice were infused with buffer for 5 d and intrahippocampally injected with 
KA. Silver staining shows that lam    1 KO mice infused with plasmin-digested laminin (C and D) exhibited much more neuronal death than control buffer  – 
infused mice (A and B), which is comparable with control (Con) mice (E and F). A higher magniﬁ  cation of the boxed areas in A, C, and E are shown in B, 
D, and F, respectively. (G) Bar graph shows the quantitative result of silver-positive cells in these three groups (  n   = 7 per group). Ln, laminin-1. Error bars 
indicate SEM. Bars: (A, C, and E) 0.5 mm; (B, D, and F) 25   μ  m.     JCB • VOLUME 183 • NUMBER 7 • 2008  1308
and activation of cell death pathways (  Kemp and McKernan, 
2002  ;   Hara and Snyder, 2007  ). 
 Although a general understanding of the process is known, 
many molecular details are unclear. In the work reported in this 
study, we shed light on two fundamental features of the cell 
death pathway: the critical role of the KA1 receptor and the role 
of proteases and the ECM. 
  KA receptors are one of the three subtypes of ionotropic 
receptors for the excitatory transmitter glutamate (  Dingledine 
et al., 1999  ). The other two subtypes are   N -methyl- d -aspartate  and 
AMPA receptors (  Mayer and Westbrook, 1987  ). KA receptors 
are tetrameric combinations of fi  ve subunits: KA1, KA2, GluR5, 
GluR6, and GluR7 (  Hollmann and Heinemann, 1994  ;   Lerma, 
2006  ). Among these subunits, GluR5, GluR6, and GluR7 have 
low affi  nity KA-binding sites, whereas KA1 and KA2 have high 
affi  nity binding sites (  London and Coyle, 1979  ;   Unnerstall and 
Wamsley, 1983  ;   Hampson et al., 1987  ). Therefore, high affi  nity 
receptors are heteromeric assemblies that include the KA1 or 
KA2 subunits, whereas receptors lacking KA1 or KA2 have 
lower affi  nity (  Contractor et al., 2003  ). GluR5  –  7 subunits can 
form functional homomeric or heteromeric receptors, whereas 
KA1 and KA2 subunits only participate in heteromeric recep-
tors and can partner with any of the GluR5  –  7 subunits (  Egebjerg 
et al., 1991  ;   Werner et al., 1991  ;   Herb et al., 1992  ;  Sommer  et al., 
1992  ;   Schiffer et al., 1997  ;   Huettner, 2003  ;   Lerma, 2003  ,   2006  ). 
dramatically less neuronal death than control IgG  –  treated neu-
rons (  Fig. 8  , g  –  j). These experiments demonstrate that inter-
fering with KA1 function protects against KA-induced neuronal 
death in vitro. 
  To investigate the in vivo neuronal protective effect of the 
anti-KA1 antibody that showed neuronal protective effect in 
vitro, we infused the antibody into the hippocampus of control 
mice and injected KA. As shown in   Fig. 9  , this antibody binds 
to fresh brain sections (  Fig. 9, A and B  ). 
[ID]FIG9[/ID]  The mice infused with 
the anti-KA1 antibody showed signifi  cantly less neuronal cell 
death after KA injection compared with control IgG  –  infused 
mice (  Fig. 9, C  –  E  ). This experiment demonstrates that the KA1 
subunit of the KA receptor plays a critical role in excitotoxic 
neuronal death in vivo. 
  Discussion 
  Excitotoxicity is a primary cause of neuronal loss in many 
neurological disorders. Many facets of this cell death pathway are 
understood. For example, in conditions such as ischemic stroke, 
loss of blood fl  ow leads to energy depletion in neurons and ac-
cumulation of excitatory amino acids like glutamate. The ex-
cess glutamate can depolarize the neurons, leading to an 
increased release of glutamate and the establishment of a dele-
terious cycle. This massive depolarization causes Ca 
2+   infl  ux 
  Figure 8.       Antibody blockage of the KA1 subunit protects neurons from KA-induced death in vitro.   (a and b) Primary cortical neuronal cultures were double 
stained with anti-TuJ1 (a) and anti-KA1 antibody (b). KA1 is expressed in the TuJ1-positive neurons in vitro. (c) In the absence of the primary antibody there 
was no staining. 14-d in vitro cortical neuronal cultures were incubated with rabbit IgG or anti-KA1 antibody for 3 h, and 50   μ  M KA was added to the 
culture media. Fresh rabbit IgG or anti-KA1 antibody was readded to the cultures 24 h later. 48 h after KA treatment, the cultures were stained for TuJ1 (d  –  f) 
or TUNEL (g  –  i). KA induced dramatic neuronal morphological changes (e) and apoptosis (h) compared with IgG treatment alone (d and g). In the anti-KA1 
antibody  –  treated cultures, neuronal morphology was preserved (f), and there were many fewer apoptotic cells (i) than in IgG-treated cultures after KA 
(e and h). (j) Quantitative analyses showed that the numbers of KA-induced TUNEL-positive nuclei in the anti-KA1 antibody  –  treated cultures were signiﬁ  -
cantly fewer than in the IgG-treated cultures (  n   = 45 for each group). Error bars indicate SEM.     1309 LAMININ AND KA1 IN EXCITOTOXIC NEURONAL DEATH   • Chen et al. 
that the protein is present in the CA1 pyramidal neuronal cell 
layers, stratum lucidum of CA3, and the polymorphic layer of DG 
under basal conditions (  Fogarty et al., 2000  ;   Darstein et al., 2003 ). 
Although studies using gene KO techniques have shed light on 
functions of KA2, GluR5, GluR6, and GluR7 subunits ( Mulle 
et al., 1998  ,   2000  ;   Contractor et al., 2003  ;   Pinheiro et al., 2007 ), 
the exact physiological and pathological functions of the KA1 
subunit are not known (  Huettner, 2003  ;   Lerma, 2003  ,   2006  ). 
  Our results demonstrated that KA1 and all other KA sub-
units are expressed in adult mouse hippocampi as determined 
by Western blotting. However, after KA injection, only KA1 
was signifi  cantly increased in wild-type mice. Further analysis 
using immunohistochemistry revealed that KA1 was mainly up-
regulated in the CA1 pyramidal neuronal cell layers. Because 
the KA1 subunit contains a high affi  nity agonist-binding site, 
increased expression may increase the binding of the receptors 
to KA and therefore sensitize neurons to excitotoxic neuronal 
death. In keeping with this idea, KA1 was not up-regulated in 
mice resistant to neuronal loss (see below). These experiments 
established a correlation between KA1 up-regulation and neu-
ronal death after KA injection. 
 Mice  defi   cient in tPA or plasminogen are resistant to 
excitotoxic neuronal death (  Tsirka et al., 1995  ,   1997  ). Analysis 
of these mice implicated the degradation of laminin as a compo-
nent of the death pathway. A likely explanation was that loss of 
laminin resulted in loss of matrix interaction and cell death 
termed anoikis (  Chen and Strickland, 1997  ;   Gilmore, 2005  ; 
  Reddig and Juliano, 2005  ). If this was the mechanism, mice 
lacking laminin in the hippocampus should be sensitized to neu-
ronal degeneration. 
  However, mice defi  cient in laminin in the hippocampus 
were resistant to neuronal loss. In tPA or lam    1 KO mice, the 
KA1 subunit was not signifi  cantly increased after KA injection. 
One mechanism that would explain the previous results with 
tPA/plasmin-defi  cient mice and the new results with hippo-
campal lam    1 KO mice was that laminin degradation released 
products that contributed to neuronal death ( Chen and Strickland, 
1997  ). Our results indicate that laminin degradation by plasmin 
generates biologically active fragments that promote neuronal 
death. In this model, loss of tPA or plasmin would protect neu-
rons because laminin would not be degraded. Laminin defi  -
ciency would also be protective because even in the presence of 
proteases, laminin degradation products would not be gener-
ated. Our results support this hypothesis. Infusion of laminin 
degradation products restores neuronal sensitivity to either lam  1 
or tPA KO mice. 
  Various studies have shown that tPA is rapidly released 
(within 30 min) upon membrane depolarization (  Gualandris 
et al., 1996  ;   Parmer et al., 1997  ;   Baranes et al., 1998  ). Laminin 
is degraded in 1  –  2 h after KA injection (  Chen and Strickland, 
1997  ). The KA1 subunit of the KA receptor is up-regulated dur-
ing the same time frame (1  –  2 h) in control mice (Fig. S5 A) but 
is not increased in either tPA or lam    1 KO mice (  Figs. 4 and 5  ). 
Because KA1 is predominantly up-regulated in the CA1 region 
of control mice after KA injection (  Fig. 4  ), the lack of KA1 up-
regulation in the CA1 region of lam    1 KO mice impaired c-fos 
induction in CA1 4 h after KA injection and the spread and 
However, the exact combinations of subunits of the KA receptor 
in different cell types and brain regions are not clear (  Huettner, 
2003 ;   Lerma,  2003 ,   2006 ). 
  In the hippocampus, KA1 mRNA localization is detected 
only in the CA3 region and DG (  Bahn et al., 1994  ;   Kask et al., 
2000  ). However, studies using immunohistochemistry showed 
  Figure 9.       KA1 antibodies bind to hippocampal neurons and inhibit KA-
induced neuronal degeneration.   (A) A control without primary antibody 
showed no staining. (B) The anti-KA1 antibody stained fresh frozen brain 
sections. (C and D) Mice were infused with control IgG or anti-KA1 anti-
body for 5 d, injected with KA, and killed 2 d later. FJB staining showed 
that infusion of anti-KA1 antibodies dramatically inhibited KA-induced neu-
ronal death. (E) Quantitative results of FJB-positive cells are shown as bar 
graphs (  n   = 7 per group). Error bars indicate SEM.     JCB • VOLUME 183 • NUMBER 7 • 2008  1310
Screaton, 2001  ;   Grossmann, 2002  ). It is possible that in some 
cases, it is not simply the loss of attachment but the generation 
of toxic degradation products from the matrix that contribute to 
cell death. This idea is similar in concept to a recent study show-
ing that fragments of collagen can have antiangiogenesis effects 
(  Marneros and Olsen, 2005  ). 
  Finally, there is no effective therapy for the neuronal death 
that occurs in ischemia. General glutamate receptor antagonists 
can protect against excitotoxic neuronal death, but such antago-
nists have dramatically deleterious effects on brain activity 
(e.g., impaired memory, decreased alertness, and coma). These 
side effects prevent their use in patients (  Kemp and McKernan, 
2002 ;  Lipton, 2006 ). Demonstration that the single subunit KA1 
is important for neuronal death suggests a more specifi  c thera-
peutic approach that might protect neurons while leaving most 
brain activity unaffected. 
  Materials and methods 
  Animals 
  Adult male mice (8  –  10 wk of age) backcrossed to C57BL6 for 10 genera-
tions were used. Lam    1 KO mice were homozygous for the ﬂ  oxed lam    1 
allele and also carried the Cre recombinase transgene under the control of 
the CaMKII promoter (  Chen and Strickland, 2003  ). Littermates homozy-
gous for the ﬂ  oxed lam    1 allele without the Cre recombinase transgene 
were used as controls. tPA KO mice on a C57BL6 background were ob-
tained from The Jackson Laboratory. 
  Intrahippocampal infusion and KA injection 
  Intrahippocampal reagent infusions were performed as described previ-
ously (  Chen and Strickland, 1997  ;   Chen et al., 2003  ). In brief, the mice 
were injected intraperitoneally with atropine (0.6 mg/kilogram of body 
weight) and were anesthetized with 2.5% avertin (0.02 ml/gram of body 
weight). They were placed on a stereotaxic apparatus (Stoelting). A micro-
osmotic pump (Alza) containing 100   μ  l puriﬁ  ed mouse laminin-1 (0.5 
mg/ml; Sigma-Aldrich), 100   μ  l plasmin-digested laminin-1 (0.5 mg/ml; 
proteases were heat inactivated after digestion), 100   μ  l anti-KA1 antibody 
(80   μ  g/ml; Santa Cruz Biotechnology, Inc.), 100   μ  l rabbit IgG (80   μ  g/ml; 
control for KA1 antibody; Sigma-Aldrich), 100   μ  l PBS (control for laminin 
infusion), or 100   μ  l of control buffers used for laminin digestion was placed 
subcutaneously in the back of the animals. A brain infusion cannula was 
inserted in the brain (at coordinates bregma,     2.5 mm; medial lateral, 
0.5 mm; and dorsoventral, 1.6 mm), and was connected to a pump to 
deliver the compound into the hippocampus. The infusion rate was 0.5   μ  l/h. 
The pumps were allowed to infuse the designated solution for 7 d. 
  For KA or PBS injection into the CA1 region, a total volume of 300 nl 
PBS or 0.5 mM KA (Tocris Cookson) for a dose of 0.15 nmol was delivered 
unilaterally using a microinjection apparatus (Stoelting) via a 2.5-  μ  l Hamilton 
syringe equipped with a 33-gauge needle over the course of 60 s. After re-
tracting the needle 0.1 mm, the needle was kept in place for 2 min to allow 
diffusion of KA, after which it was completely removed. The coordinates for 
the injections were bregma,     2.5 mm; medial lateral, 1.7 mm; and dorso-
ventral, 1.6 mm. The mice were perfused through the heart with ice-cold 
saline (for Western blotting) or further perfused with 4% PFA in 0.1 M 
phosphate buffer, pH 7.4 (for immunohistochemistry), for either 2 h , 4 h, 
6 h, 2 d, or 6 d after experimental injections. For Western blot analyses, 
the hippocampi were collected in dry ice. For immunohistochemistry, the 
brains were removed, postﬁ  xed overnight at 4  °  C, and incubated in 30% 
sucrose in PBS for 48 h at 4  °  C. 30-  μ  m coronal brain sections were cut on 
a microtome, collected in PBS, and processed for further analysis. 
  Immunohistochemistry 
  Immunohistochemistry was performed as previously described (  Chen et al., 
1999  ). In brief, brain sections were washed in PBS and blocked in 0.3% 
Triton X-100 and 5% proper normal serum in PBS. The primary antibodies 
used were rat anti-lam    1 (1:50; Millipore), rabbit anti  –  c-fos (1:500; EMD), 
and goat anti-KA1 receptor (1:100; Santa Cruz Biotechnology, Inc.). The 
sections were incubated overnight with primary antibody in 0.3% Triton 
X-100 and 3% normal serum in PBS at 4  °  C. After rinsing in PBS, the sections 
maintenance of c-fos expression in other regions of the hippo-
campus at later time points (  Fig. 2 A  ). The timing of these mo-
lecular changes supports our hypothesis that plasmin-mediated 
degradation of laminin up-regulates the KA1 subunit, which is 
necessary for c-fos induction and neuronal cell death in the CA1 
region of the hippocampus. 
  Infusion of plasmin-digested laminin into the hippo  campus 
of either tPA or lam    1 KO mice restored KA1 up-regulation 
after KA injection. However, infusion of intact laminin only 
restored KA1 up-regulation in lam    1 KO mice but not in tPA 
KO mice (  Fig. 6  ). Lam    1 KO mice would still generate plas-
min activity after KA, which could degrade the infused intact 
laminin. In contrast, the infused intact laminin could not be 
degraded in tPA KO mice because there is no tPA to activate 
plasminogen, and thus KA1 was not up-regulated. Therefore, 
the degradation products of laminin generated by plasmin play 
an important role in KA1 up-regulation. These experiments 
showed that proteolytic fragments of laminin can regulate 
KA1 subunit expression and therefore modulate excitotoxic 
neuronal degeneration. However, the mechanism by which 
laminin fragments regulate KA1 subunit expression is cur-
rently unclear. For example, laminin fragments could bind to 
as yet unidentifi  ed receptors and activate intracellular signal-
ing pathway to regulate KA1 subunit expression. Laminin 
fragments could regulate KA1 expression at transcriptional, 
translational, or posttranslational levels. 
  Based on previous work (  Tsirka et al., 1995  ,   1997  ;   Chen 
and Strickland, 1997  ;   Nagai et al., 1999  ;   Chen et al., 2003  ) and 
our current results, we propose a new model of excitotoxic 
neuronal death. In the presence of excess excitatory amino 
acid, tPA is released from neurons and converts plasminogen 
to plasmin. Plasmin catalyzes the degradation of laminin, gen-
erating laminin fragments that up-regulate the KA1 subunit of 
KA receptors. Up-regulation of KA1 could bias the subunit 
composition of KA receptors so that more KA1 subunits par-
ticipate in channel formation. Alternatively, increased expres-
sion of KA1 subunits could increase the number of KA 
receptors, which would be composed of one KA1 subunit with 
other subunits. Either one of these changes would lead to an 
increased ratio of KA1 subunits. Because the KA1 subunit is a 
high affi  nity site for KA, this occurrence would increase the 
affi  nity of the receptors to KA, therefore promoting excitotoxic 
neuronal death. 
  The up-regulation of the KA1 subunit mainly occurred in 
the CA1 region of the hippocampus, which normally exhibits 
low KA1 expression. Therefore, KA-induced excitotoxic neu-
ronal death in CA1 may represent an effect of KA that is sec-
ondary to the up-regulation of KA1 subunits. In support of this 
idea, interfering with KA1 function by anti-KA1 antibodies 
dramatically decreased neuronal loss after KA injection. Given 
the location of KA1 up-regulation, it is possible that our model 
is most relevant to those pathologies in which neuronal death 
occurs mostly in the CA1 region. 
  Our results have implications for the mechanisms by 
which the ECM controls cell viability. It has been shown that 
the loss of the matrix attachment can lead to cell death via anoikis 
(  Meredith et al., 1993  ;   Frisch and Ruoslahti, 1997  ;   Frisch and 1311 LAMININ AND KA1 IN EXCITOTOXIC NEURONAL DEATH   • Chen et al. 
  To determine the effect of anti-KA1 antibodies on KA-induced neu-
ronal death in vitro, 14-d in vitro neuronal cultures were washed with 
NeuroBasal media three times to remove dead cells. The neuronal cultures 
were incubated in fresh growth media overnight, and control IgG or anti-
KA1 antibodies were added to the media and incubated for 3 h. 50   μ  M 
KA was added to the media and incubated for 48 h. Additional control 
IgG or anti-KA1 antibodies were added to the cultures 24 h after the ﬁ  rst 
addition. Neuronal cultures were ﬁ  xed in 4% PFA and processed for TuJ1 
immunocytochemistry and terminal deoxynucleotidyl transferase  –  mediated 
biotinylated UTP nick-end labeling assay (TUNEL staining). TUNEL stain-
ing was performed using the In Situ Cell Death Detection kit (Roche) 
according to the instructions of the manufacturer. Neuronal cultures were 
permeabilized in 0.1% Triton X-100/0.1% sodium citrate on ice for 2 min 
and incubated with the TUNEL reaction mixture at 37  °  C for 1 h in a hu-
midiﬁ  ed chamber. After TUNEL staining, the cultures were incubated with 
mouse anti-TuJ1 antibody (1:1,000; Covance), and the staining was visu-
alized using ﬂ  uorescent dye  –  conjugated donkey anti  –  mouse IgG. Nuclei 
were counterstained with DAPI. TUNEL and DAPI double-labeled nuclei 
were determined. Five random ﬁ  elds were analyzed in each culture well, 
and each experiment group was composed of three wells. The statistical 
analyses were based on results from three different batches of cultures. 
The differences in percentage of TUNEL-positive nuclei in different groups 
were analyzed by one-way ANOVA. 
  Image analysis 
  All images were acquired by using an AxioVision System (Carl Zeiss, 
Inc.) under a microscope (Axiovert 200; Carl Zeiss, Inc.) using a cam-
era (Axiocam; Carl Zeiss, Inc.), and images were processed with Pho-
toshop (Adobe). 
  Online supplemental material 
  Fig. S1 shows KA-induced neuronal death in the CA2/3 region of lam    1 
KO mice and the long-term neuronal protective effect of lam    1 deﬁ  ciency. 
Fig. S2 shows that AMPA receptor subunits are not changed in either 
control or lam    1 KO mice after KA injection. Fig. S3 shows speciﬁ  city 
of the anti-KA1 antibodies and the effect of plasmin-digested laminin on 
KA1 up-regulation. Fig. S4 shows that infusion of plasmin-digested lam-
inin into tPA KO mice restores neuronal sensitivity to excitotoxicity. Fig. S5 
shows that KA1 up-regulation precedes neuronal death after KA injec-
tion. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200803107/DC1. 
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